Men in methadone maintenance versus psychosocial outpatient treatment: Differences in sexual risk behaviors and intervention effectiveness from a multisite HIV prevention intervention trial

Journal of Addictive Diseases

Volumn 29, Issue 3, 2010, Pages 370-382

  Calsyn, Donald A ^a,b   Campbell, Aimee N C ^c   Crits Christoph, Paul ^d   Doyle, Suzanne R ^a   Tross, Susan ^c,e   Hatch Maillette, Mary A ^a,b   Mandler, Raul ^f  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Columbia University ^*  (United States)

^f NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

behavioral intervention; HIV prevention; sexual risk reduction; substance abuse treatment modality

Indexed keywords

(1 BUTYLAMINO 3 METHYLBUTYL)(1 PYRROLIDINYL) KETONE; METHADONE; OPIATE; STREET DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; FOLLOW UP; HEALTH PROGRAM; HIGH RISK BEHAVIOR; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OUTPATIENT CARE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; SAFETY; SEXUAL BEHAVIOR; SOCIAL ASPECT; AMBULATORY CARE; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CONDOM; DRUG DEPENDENCE TREATMENT; EDUCATION; HEALTH EDUCATION; HIV INFECTIONS; MIDDLE AGED; MULTICENTER STUDY; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; PROGRAM DEVELOPMENT; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; TRANSMISSION; TREATMENT OUTCOME; UNSAFE SEX; UTILIZATION;

ADULT; AMBULATORY CARE; COMORBIDITY; CONDOMS; EDUCATION; FOLLOW-UP STUDIES; HEALTH EDUCATION; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; PROGRAM DEVELOPMENT; RISK FACTORS; STREET DRUGS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNSAFE SEX;

EID: 77954728529     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2010.489451     Document Type: Article

References (42)

1. Center for Disease Control and Prevention. HIV/AIDS Surveillance Report, Volume 19, 2007. Atlanta, GA: US Department of Health andHuman Services, Center for Disease Control and Prevention, 2009.
2. Molitor F, Truax SR, Ruiz JD, Sun RK. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med 1998; 168:93-97
3. Rawson RA, Washton AW, Domier CP, Reiber C. Drugs and sexual effects: role of drug type and gender. J Subst Abuse Treat 2002; 22:103-108
4. Shoptaw S, Reback CJ, Frosch DL, Rawson RA. Stimulant abuse treatment as HIV prevention. J Addict Dis 1998; 17:19-32.
5. Metzger D, Navaline H,Woody G. Drug abuse treatment is AIDS prevention. Pub Health Rep 1988; 113(suppl 1):97-106.
6. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend 2000; 59:17-31.
7. Farrell M, Gowing L, Marsden J, Ling W, Ali R. Effectiveness of drug dependence treatment in HIV prevention. Int J Drug Policy 2005; 16S:S67-75.
8. Shoptaw S, Tross S, Stephens M, Tai B, the NIDA CTN HIV/AIDS Workgroup. A snapshot of HIV/AIDSrelated services in the clinical treatment providers for NIDA's Clinical Trials Network. Drug Alcohol Depend 2002; 66(S1):S163.
9. Grella CE, Etheridge RM, Joshi V, Anglin MD. Delivery of HIV risk-reduction services in drug treatment programs. J Subst Abuse Treat 2000; 19:229-237
10. PrendergastM, Urada D, Podus D. Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. J Consult Clin Psychol 2001; 69:389-405.
11. Copenhaver MM, Johnson BT, Lee I, Harman JJ, Carey MP, the SHARP Research Team. Behavioral HIV risk reduction among people who inject drugs: Metaanalytic evidence of efficacy. J Subst Abuse Treat 2006; 31:163-171
12. Semaan S, Des JarlaisDC, SogolowE, Johnson WD, Hedges LV, Ramirez G, Flores SA, Norman L, Sweat MD, Needle R. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acq Immun Def Synd 2002; 30(suppl 1):S73-93.
13. The NIMH Multisite HIV Prevention Trial Group. The NIMH Multisite HIV Prevention Trial: Reducing HIV Sexual Behavior Risk. Science 1998; 280:1889-1894
14. Bartholomew NG, Simpson DD. Time out! For men: a communication skills and sexuality workshop for men. Fort Worth, TX: Institute for Behavioral Research, Texas Christian University, 1996.
15. Bartholomew NG, Hiller ML, Knight K, Nucatola DC, Simpson DD. Effectiveness of communication and relationship skills training for men in substance abuse treatment. J Subst Abuse Treat 2000; 18:217-225
16. Calsyn DA, Hatch-Maillette M, Tross S, Doyle SR, Crits-Christoph P, Song YS, Harrer JM, Lalos G, Berns SB.Motivational and Skills Training HIV/STI Sexual Risk Reduction Groups for Men. J Subst Abuse Treat 2009; 37:138-150
17. Calsyn DA, Crits-Christoph P, Hatch-Maillette M, Doyle SR, Song YS,Coyer S, Pelta S. Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment. Addiction 2010; 105:100-108.
18. Raj A, Saitz R, Cheng DM, Winter M, Samet JH. Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse 2007; 33:169-178
19. Volkow ND, Wang G, Fowler JS, Telang F, Jayne M, Wong C. Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. Am J Psychiatry 2007; 164:157-160
20. Al-Gommer O, George S, Haque S, Mosethy H, Saravanappa T. Sexual dysfunctions in male opiate users: A comparative study of heroin, methadone, and buprenorphine. Addict Dis Thr Treat 2007; 6:137-143
21. Palha AP, Esteves M. A study of the sexuality of opiate addicts. J Sex Marital Ther 2002; 28:427-437
22. Simpson D, Brown BS, Joe GW. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11:294-307. (Pubitemid 28046591)
23. Simpson DD, Joe GW, Broome KM, Hiller ML, Knight K, Rowan-Szal G. Program diversity and treatment retention rates in theDrugAbuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11:279-293
24. Etheridge RM, Hubbard RL, Anderson J, Craddock SG, Flynn PM. Treatment structure and program services in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11:244-260 (Pubitemid 28046588)
25. Folstein MF, Folstein SE, McHugh PR. "Mini- Mental State": a practical method for grading cognitive state of patients for the clinician. J Psychiat Res 1975; 12:196-198
26. Cockrell JR, Folstein, MF. Mini-Mental State Examination. Psychopharmacol Bull 1988; 24:689-692
27. CalsynDA,Wells EA, Saxon AJ, JacksonR, Heiman JR. Sexual activity under the influence of drugs is common among methadone clients. In L. S. Harris (Ed). Problems of Drug Dependence 1999, NIH Pub. No.00-4773. Rockville, MD: National Institute on Drug Abuse, 2000:315.
28. Meyer-Bahlburg H, Ehrhardt A, Exner TM, Gruen RS. Sexual Risk Behavior Assessment Schedule-Adult Armory Interview (SERBAS-A-ARM). New York: New York State Psychiatric Institute and Columbia University, 1991.
29. Sohler N, Colson PW,Meyer-Bahlberg HFL, Susser E. Reliability of self reports about sexual risk behaviors for HIV among homeless men with severe mental illness. Psychiatr Serv 2000; 51:814-816
30. Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S. Randomized controlled trial of audio computer-assisted self-interviewing: Utility and acceptability in longitudinal studies. Am J Epidemiol 2000; 152:99-106.
31. Gross M, Holte SE, Marmor M, Mwatha A, Koblin BA,Mayer KM. Anal sex among HIV-seronegative women at high risk of HIV exposure. J Acquir Immune Defic Syndr 2000; 24:393-398
32. McLellan AT, Cacciola J, Kushner H, Peters F, Smilth L, Pettinati H. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199-213.
33. March JS, Silva SG, Compton S, Shapiro M, Califf R, Krishnan R. The case for practical clinical trials in psychiatry. Am J Psychiatry 2005; 162:836-846
34. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003; 290:1624-1632
35. Hedeker D, Gibbons RD. Longitudinal Data Analysis. Hoboken, NJ: John Wiley & Sons, 2006.
36. Lambert D. Zero-inflated Poisson regression with an application to defects in manufacturing. Technometrics 1992; 34:1-14.
37. Cohen C. Statistical Power Analysis for the Behavioral Sciences, 2nd Ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
38. Verdejo A, Toribio I, Orozco C, Puente KL, Perez- Garcia M. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend 2005; 78:283-288
39. Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D, Diana M. Impaired decision-making in opiatedependent subjects: effect of pharmacological therapies. Drug Alcohol Depend 2006; 83:163-168
40. Fishbein DH, Krupitsky E, Flannery BA, Langevin DJ, Bobashev G, Verbitskaya E, Augustine CB, Bolla KI, Zvartau E, Schech B, Egorova V, Bushara N, Tsoy M. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend 2007: 90:25-38.
41. Grohman K, Fals-Stewart W. Computer-assisted cognitive rehabilitation with substance-abusing patients: Effects on treatment response. J Cognitive Rehab 2003; 21:10-17
42. Copenhaver MM, Avants SK, Warburton LA, Margolin A. Intervening effectively with drug abusers infected with HIV: Taking into account the potential for cognitive impairment. J Psychoactive Drugs 2003; 35: 209-218